Patent · US Expired

Retrovirus from the HIV group and its use (MVP-2901/94)

US6162631A · kind A · utility

2Cited by

3References

6Claims

0Family size

Assignee

Behringwerke Aktiengesellschaft · DE

Inventors

Hans-Peter Hauser · Marburg, DE
Stefan Knapp · Marburg, DE
Stefan Brust · Marburg, DE
Lutz G. Gürtler · Munich, DE
Josef Eberle · Freising, DE
Lazare Kaptue · Brüggen, DE
Leopold Zekeng · Brüggen, DE

Key dates

Filing date	Dec 12, 1997
Grant date	Dec 19, 2000
Priority date	—
Expiry date	Dec 12, 2017

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/812
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A novel immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.